Advertisement
Advertisement
SNYR
Synergy CHC Corp. Common Stock
0.39
USDSponsored
-0.01
-1.29%
May 08, 15:59 UTC -4
Closed
After-Market
0.39
0.00
-0.38%
SNYR Earnings Reports
Positive Surprise Ratio
SNYR beat 2 of 5 last estimates.
40%
Next Report
In 3 Days
Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
$9.72M
/$0.03
Implied change from Q4 25 (Revenue/ EPS)
+60.11%
/-104.17%
Implied change from Q1 25 (Revenue/ EPS)
+18.95%
/-70.00%
Synergy CHC Corp. Common Stock earnings per share and revenue
On Apr 01, 2026, SNYR reported earnings of -0.72 USD per share (EPS) for Q4 25, missing the estimate of 0.01 USD, resulting in a -7158.82% surprise. Revenue reached 6.07 million, compared to an expected 11.05 million, with a -45.05% difference. The market reacted with a +6.61% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 3 analysts forecast an EPS of 0.03 USD, with revenue projected to reach 9.72 million USD, implying an decrease of -104.17% EPS, and increase of 60.11% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
Concentra Group Holdings Parent, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$0.34
Actual
$0.40
Surprise
+17.03%
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
LifeMD, Inc. Common Stock
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.22
Actual
-$0.20
Surprise
+12.85%
FAQ
What were Synergy CHC Corp. Common Stock's earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Synergy CHC Corp. Common Stock reported EPS of -$0.72, missing estimates by -7158.82%, and revenue of $6.07M, -45.05% below expectations.
How did the market react to Synergy CHC Corp. Common Stock's Q4 2025 earnings?
The stock price moved up 6.61%, changed from $1.21 before the earnings release to $1.29 the day after.
When is Synergy CHC Corp. Common Stock expected to report next?
The next earning report is scheduled for May 13, 2026.
What are the forecasts for Synergy CHC Corp. Common Stock's next earnings report?
Based on 3
analysts, Synergy CHC Corp. Common Stock is expected to report EPS of $0.03 and revenue of $9.72M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement